Acurx Pharmaceuticals (ACXP) Stock Chart & Stock Price History $0.74 -0.01 (-1.97%) Closing price 04:00 PM EasternExtended Trading$0.73 -0.01 (-1.08%) As of 05:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Acurx Pharmaceuticals Stock Price Performance 5 Day Performance-4.43%1 Month Performance+5.71%3 Month Performance-58.19%6 Month Performance-61.05%Year-To-Date Performance-9.09%1 Year Performance-75.25% Receive ACXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address ACXP Stock Chart for Friday, February, 14, 2025 ACXP Chart by TradingView Acurx Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/13/2025$0.74$0.76+1.73%$0.76$0.7435,237 shs$12.89 million02/12/2025$0.74$0.74+0.27%$0.76$0.7454,631 shs$12.67 million02/11/2025$0.76$0.74-2.21%$0.77$0.7355,839 shs$12.64 million02/10/2025$0.77$0.76-2.00%$0.79$0.7539,453 shs$12.92 million02/07/2025$0.78$0.77-1.31%$0.79$0.7656,487 shs$13.19 million02/06/2025$0.80$0.78-1.70%$0.80$0.7563,551 shs$13.36 million02/05/2025$0.78$0.80+2.33%$0.82$0.76123,383 shs$13.59 million02/04/2025$0.73$0.78+6.83%$0.78$0.7363,002 shs$13.28 million02/03/2025$0.73$0.73-0.07%$0.75$0.72117,479 shs$12.43 million01/31/2025$0.76$0.73-3.74%$0.76$0.72104,876 shs$12.44 million Get the Latest News and Ratings for ACXP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 01/30/2025$0.73$0.76+3.97%$0.76$0.71135,679 shs$12.93 million01/29/2025$0.78$0.73-6.05%$0.78$0.70144,131 shs$12.43 million01/28/2025$0.84$0.78-7.50%$0.85$0.76145,969 shs$13.23 million01/27/2025$0.87$0.84-3.63%$0.87$0.8373,729 shs$14.31 million01/24/2025$0.83$0.87+5.25%$0.87$0.8389,434 shs$14.84 million01/23/2025$0.85$0.83-2.36%$0.85$0.8299,818 shs$14.10 million01/22/2025$0.89$0.85-4.71%$0.90$0.82206,781 shs$14.44 million01/21/2025$0.88$0.89+0.79%$0.90$0.82403,090 shs$15.16 million01/20/2025$0.88$0.88$0.91$0.78683,597 shs$15.04 million01/17/2025$0.79$0.88+12.20%$0.91$0.78683,597 shs$15.04 million01/16/2025$0.72$0.79+9.32%$0.80$0.71329,147 shs$13.40 million01/15/2025$0.70$0.72+2.84%$0.73$0.69154,948 shs$12.26 million01/14/2025$0.70$0.70$0.73$0.68502,879 shs$11.92 million01/13/2025$0.81$0.70-13.39%$0.79$0.69756,640 shs$11.83 million Related Companies AlloVir Stock Price Chart Atara Biotherapeutics Stock Price Chart FibroGen Stock Price Chart Ovid Therapeutics Stock Price Chart Achilles Therapeutics Stock Price Chart Aileron Therapeutics Stock Price Chart Nabriva Therapeutics Stock Price Chart Kezar Life Sciences Stock Price Chart Annovis Bio Stock Price Chart ImmuCell Stock Price Chart Receive ACXP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ACXP) was last updated on 2/14/2025 by MarketBeat.com Staff From Our Partners*Breaking News!* This Pharma NASDAQ Company and the U.S Army!!! This Little Known NASDAQ Company just released positive results from its drugs that have been undergoing testi...Trading Wire | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredTexas approves new currencyRural Texas Town Ramps Up Global Currency War A small town has joined a radical $1.9 trillion attack on the...Stansberry Research | SponsoredElon’s #1 investment during Trump’s termWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a reason you don't hear about this Tesla income secret from traditional financial advisors. It's ne...Investors Alley | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plan...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acurx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acurx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.